News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Connaughton Bernadette
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/28/2023 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on Syneos Health, Inc.
Txns:
| Disposed/sold 9,915 shares
@ $43, valued at
$426.3k
Disposed/sold 4,863 shares
@ $0 |
|
05/30/2023 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on Syneos Health, Inc.
Txns:
| Granted 4,863 shares
@ $0 |
|
05/09/2023 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns:
| Granted 8,065 shares
@ $0 Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
11/17/2022 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns:
| Gifted 5,998 shares
@ $0 |
|
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/28/2021 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on Editas Medicine, Inc.
Txns:
| Granted 24,732 options to buy
@ $37.9, valued at
$937.3k
|
|
10/28/2021 |
3
| Connaughton Bernadette (Director) has filed a Form 3 on Editas Medicine, Inc. |
05/14/2021 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on Syneos Health, Inc.
Txns:
| Granted 2,364 shares
@ $0 |
|
05/06/2021 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns:
| Granted 5,230 restricted stock units
@ $0 |
|
05/29/2020 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on Syneos Health, Inc.
Txns:
| Granted 2,803 shares
@ $62.43, valued at
$175k
|
|
05/01/2020 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns:
| Granted 8,829 shares
@ $0 |
|
11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/03/2019 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on HALOZYME THERAPEUTICS INC
Txns:
| Granted 12,173 shares
@ $0 |
|
09/11/2018 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on HALOZYME THERAPEUTICS INC
Txns:
| Granted 5,781 shares
@ $0 |
|
09/11/2018 |
3
| Connaughton Bernadette (Director) has filed a Form 3 on HALOZYME THERAPEUTICS INC |
|
|